I-milk thistle (i- Silybum marianum ) isitshalo sathi sinempahla ekhuthaza impilo yesibindi. Imbewu iqukethe i-silymarin, iqembu lama-compounds (kufaka phakathi i-silybin, i-silydianin, ne-silychristin) lathi libe nemiphumela ephikisana ne-antioxidant ne-anti-inflammatory futhi ivikela amaseli wesibindi.
Okwenza Abantu Bisebenzise
Ngesikhathi ubisi lwe-milk thistle luvame ukusetshenziselwa izimo zesibindi, njenge-hepatitis kanye ne-cirrhosis, isitshalo kuthiwa silwe nalezi zinkinga zezempilo:
- Ukucindezeleka
- Isifo sikashukela
- Izifo ze-Gallbladder
- I-Hangovers
- Ukuguquka kwenhliziyo
- I-cholesterol ephakeme
- Ukuphikiswa kwe-insulin
- Izinkinga zokuya esikhathini
- Isifo sikaParkinson
- Izifo zonyaka
Abanye abaxhasile bathi futhi ubisi lwe-thistle lungakwazi ukuvikela izinhlobo ezithile zomdlavuza, kuhlanganise nomdlavuza webele kanye nomdlavuza wesifo sofuba.
Izinzuzo zezeMpilo
Nakhu ukubuka isayensi ngemuva kwezinzuzo zezempilo ezikhona zobisi thistle:
1) Izifo zesibindi
Olunye ucwaningo lokuqala lubonisa ukuthi i-silymarin ingathuthukisa ukusebenza kwesibindi ngokugcina izinto ezinobuthi kusukela ekubopheleleni kumaseli we-isibindi. Kodwa-ke, ukuhlolwa kokusebenza kobisi lwe-thistle ekwelapheni izinkinga zesibindi kuye kwaveza imiphumela ehlanganisiwe.
Isibonelo, ubufakazi obuningi bemitholampilo bubonisa ukuthi ubisi lwe-thistle alukhulisi umsebenzi wesibindi noma ukunciphisa ingozi yokufa kubantu abanezidakamizwa zesibindi, u-hepatitis B, noma i-hepatitis C, ngokusho kombiko oshicilelwe kuyi- American Journal of Gastroenterology ngo-2005.
Ngaphezu kwalokho, ezinye izifundo ezincane zibonise ukuthi u-milk thistle ungathuthukisa ukusebenza kwesibindi kubantu abane-cirrhosis, kanti ezinye izilingo zomtholampilo zibonise ukuthi ubisi lwe-thistle lungase lube nenzuzo encane noma ayikho inzuzo kubantu abanesifo.
2) I-Hepatitis C
Ngesinye isikhathi i-thistle yobisi isetshenziswa abantu abane-hepatitis C engapheli (ukutheleleka kwesandulela ngculaza okungakwazi ukuhlasela nokulimaza isibindi).
Ucwaningo olwenziwa ngabahlanganyeli abangu-1 145 ku-HALT-C e-NIH eyayixhaswe ngemali (i-Hepatitis C Anti-Terminal Treatment Against Cirrhosis). Icwaningo lathola ukuthi amaphesenti angu-23 wabathintekayo basebenzisa izithako ze-herbal, kanti ubisi luba yiyona ndlela evame kakhulu.
Ukuhlolisisa imibono yabasebenzi bezokwelapha kanye nokuphila, abahlanganyeli babike ukuthi ubisi lwe-milk thistle buhlotshaniswa nezimpawu ezimbalwa nezimbi zesifo sesibindi kanye nempilo engcono kangako, kodwa-ke, kwakungekho ushintsho kumsebenzi wegciwane noma izinga lokuvuvukala esibindi.
Isivivinyo sika-2012 eshicilelwe ku- JAMA sibheke ukusetshenziswa kobisi thistle (420 mg silymarin noma 700 mg silymarin, esithathwe kathathu ngosuku) noma i-placebo yamaviki angu-24. Ekupheleni kwenkathi yokwelapha, abacwaningi bathola ukuthi ubisi lwe-thistle alukho kangcono kune-placebo ekunciphiseni izinga legazi le-enzyme ebonisa ukulimala kwesibindi.
Esinye isifundo, eshicilelwe ku- BioMed Research International , sibheke izifundo ezishicilelwe ngaphambilini kwi-silymarin kubantu abanesifo sengculaza esingapheli nesifo sofuba. Ekuhlaziyweni kwabo, i-silymarin ayitholakalanga ukuthi ibengcono kune-placebo ekwenzeni ngcono ama-laboratory values (ALT ne-HCV RNA) noma izinga lokuphila.
3) Isifo sikashukela
Ucwaningo oluthile lubonise ukuthi ubisi lwe-thistle lungabasiza abantu abanesifo sikashukela.
Ucwaningo lwamuva kakhulu ngobisi lwe-thistle nesifo sikashukela luhlanganisa ucwaningo olushicilelwe ePhytomedicine ngonyaka ka-2015. Ukuze kuhlolwe, abantu abangu-40 abane-sikashukela baphathwa nge-silymarin noma i-placebo izinsuku ezingu-45. Ekupheleni kokutadisha, amalungu eqembu le-silymarin abonise ukuthuthukiswa okukhulu kwe-antioxidant amandla nokunciphisa okukhulu ukuvuvukala uma kuqhathaniswa nalabo abanikezwa i-placebo.
Ngokusho kwabalobi bezocwaningo, lokhu okutholakele kuphakamisa ukuthi i-silymarin ingase izuze iziguli zesifo sikashukela ngokunciphisa ukucindezeleka kwe-oxidative (inqubo eyaziwa ukuthi idlala indima enkulu ekuthuthukiseni izinkinga zesifo sikashukela).
Ukwengeza, izinhlolo eziningana zemitholampilo eyenziwa eminyakeni yamuva zithole ukuthi ubisi lwe-thistle lungasiza ekulawuleni isifo sikashukela ngokulawula amazinga kashukela egazini nokuvimbela ukulimala kwezinso ezihlobene nesifo sikashukela.
Funda kabanzi mayelana nobisi lwe-thistle nesifo sikashukela .
4) Izifo Zonyaka Zonyaka
Ucwaningo oluncane olwanyatheliswa ku- Otolaryngology ne- Head and Neck Surgery ngo-2011 lubonisa ukuthi i-silymarin ingasiza ekunakekeleni izifo zonyaka. Esivivinyweni somtholampilo esibandakanya abantu abangu-94 abanezinkinga zonyaka, abacwaningi baphawula ukuthi labo abaphathwa nge-silymarin inyanga eyodwa babenokuthuthuka okuphawulekayo kakhulu ekugqibeleni kwezimpawu zabo (uma kuqhathaniswa nalabo abanikezwa i-placebo inyanga eyodwa).
Imiphumela Ezingenakwenzeka
Ubisi obunamanzi bungabangela imiphumela eminye emibi, kuhlanganise ne-nausea, isifo sohudo, ukuvuvuka kwesisu, negesi. Kungabangela ikhanda, ukuhlukumezeka, ubuhlungu obuhlangene, nokuhlukumeza ngokocansi. Ukusabela okwenziwe okwenziwe nge-allergenic okunjengezinyosi nokuphefumula kunzima. Abantu abane-allergies kuya ku-daisies, i-artichokes, i-kiwi, i-thistle evamile, noma izitshalo emndenini we-aster kungase kube nokwelapha ubisi lwe-thistle.
Ucwaningo olwanyatheliswa kuyi- International Journal of Food Microbiology lathola ukuthi amaphesenti amaningi e-milk thistle supplement ahlolwa ahlotshiswe ngesikhunta. Imbewu yonke yayinamazinga aphakeme kakhulu, alandelwe umuthi (akukho fungi ephilayo etholakala emasakeni esikheyi, ama-extracts, ama-capsules, noma ama-gels aphansi). Amafungulu akhiqiza izidakamizwa ezinobuthi ezibizwa ngokuthi i-mycotoxins.
Ubisi lwezinyosi bunganciphisa amazinga kashukela egazi, ngakho kufanele isetshenziswe ngokucophelela ngabantu abanesifo sikashukela kanye nanoma ubani ophuza imithi noma izithako ezithinta amazinga kashukela egazini.
Njengoba kunobungozi bokuthi ubisi lwe-thistle bungaba nemiphumela efana ne-estrogen, abantu abanezimo ezibuhlungu njenge-endometriosis, i-uterine fibroids, noma umdlavuza webele, isisu noma ama-ovari kufanele bagweme ubisi lwe-milk thistle. I-milk thistle ingase ithole ukunciphisa ukuphumelela kwemithi yokwelapha ngomlomo ngokuvimbela i-enzyme ebizwa ngokuthi i-beta-glucuronidase.
Ubisi obunamanzi bungashintsha indlela umzimba wakho owenza ngayo izidakamizwa esibindi futhi uhlanganyele nemithi.
Abesifazane abakhulelweyo nabancelisayo kufanele bagweme ubisi thistle. Ungathola amathiphu ekusetshenzisweni izithako lapha , kodwa khumbula ukuthi i-FDA ayilawuli imithetho yokudla, ngakho ukuhlanzeka nomthombo kungashintsha kakhulu. uma ucabangela ukusebenzisa ubisi thistle, qiniseka ukuthi ukhuluma nomhlinzeki wakho wezempilo kuqala.
Lapho Uzoyithola khona
Izithako zokudla eziqukethe ubisi lwe-thistle zithengiswa ezitolo eziningi zemvelo zokudla, izidakamizwa nezitolo ezikhethekile emikhiqizo ye-herbal. Ungabuye futhi uthenge imikhiqizo yobisi ye-thistle online.
Ngaphansi
Ngenkathi ukuhlolwa kwebhulabhu kubonisa ukuthi ubisi lwe-thistle lunempahla ezuzisayo, ukuphumelela kobisi lwe-thistle ukwelashwa kwesibindi nezinye izimo kudingeka kuhlolwe ngokuqhubekayo ezinkulweni ezinkulu zabantu ezihlelwe kahle. Uma unesithakazelo ekufundeni okuningi ngakho, khuluma nomhlinzeki wakho wokunakekelwa kwezempilo ukuze ubone ukuthi kufanelekile yini.
Imithombo:
> Ebrahimpour Koujan S, Gargari BP, Mobasseri M, Valizadeh H, Asghari-Jafarabadi M. Imiphumela kaSilybum marianum (L.) Gaertn. (silymarin) ukukhipha ukwesekwa kwesimo se-antioxidant kanye ne-hs-CRP ezigulini ezine-type 2 yesifo sikashukela esinesisindo: isilingo somtholampilo esilawulwa ngokungahleliwe, esinezintathu, esiyimpumputhe. I-Phytomedicine. 2015 Feb 15; 22 (2): 290-6.
> MW othosiwe, i-Navarro VJ, i-Afdhal N, et al. Umphumela we-silymarin (ubisi thistle) esibhedlela sesibindi kweziguli ezine-hepatitis C ezingapheli ezingaphathwa kahle nge-interferon therapy: isilingo esilawulwa ngokungahleliwe. I-JAMA. 2012 Jul 18; 308 (3): 274-82.
> I-Rambaldi A, Jacobs BP, i-Iququinto G, i-Gluud C. Ubisi lobisi lwe-alcoholic kanye / noma i-hepatitis B noma i-C yezifo zesibindi - ukubuyekezwa kwamaqembu we-cochrane-hepato-biliary we-cochrane kanye nokuhlaziywa kwemithi yokuhlolwa kwamakhambi. Am J Gastroenterol. 2005 Nov; 100 (11): 2583-91.
> Seeff LB, Curto TM, Szabo G, et al. Ukusetshenziswa komkhiqizo wamagciwane ngabantu ababhalisile kwi-Hepatitis C Yokuvimbela Ukuvimbela Umuthi Wokuguqula Isikhathi Esiyisikhathi Sokulwa Nomzimba We-Cirrhosis (HALT-C). I-Hepatology. 2008; 47 (2): 605-612.
> Yang Z, Zhuang L, Lu Y, Xu Q, Chen X. Imiphumela kanye nokubekezelelana kwe-silymarin (ubisi thistle) kwiziguli ezingapheliyo zokutheleleka ngegciwane lesandulela ngculaza: ukuhlaziywa kwe-meta-analysis of randomzed controls. I-Res Int Res. 2014; 2014: 941085.
Ukuziphendulela: Ulwazi oluqukethwe kule sayithi luhloswe ngezinjongo zemfundo kuphela futhi aluthathi iseluleko, ukuxilongwa noma ukwelashwa ngudokotela olayisensi. Akuhloselwe ukumboza zonke izinyathelo zokuqapha, ukusebenzisana kwezidakamizwa, izimo noma imiphumela emibi. Kufanele ufune ukunakekelwa okusheshayo kwezokwelapha kunoma yiziphi izinkinga zezempilo bese uthintana nodokotela wakho ngaphambi kokusebenzisa enye imithi noma wenze ushintsho ohlelweni lwakho.